SG11202106179VA - Multivalent pneumococcal polysaccharide-protein conjugate vaccine - Google Patents
Multivalent pneumococcal polysaccharide-protein conjugate vaccineInfo
- Publication number
- SG11202106179VA SG11202106179VA SG11202106179VA SG11202106179VA SG11202106179VA SG 11202106179V A SG11202106179V A SG 11202106179VA SG 11202106179V A SG11202106179V A SG 11202106179VA SG 11202106179V A SG11202106179V A SG 11202106179VA SG 11202106179V A SG11202106179V A SG 11202106179VA
- Authority
- SG
- Singapore
- Prior art keywords
- protein conjugate
- conjugate vaccine
- pneumococcal polysaccharide
- multivalent pneumococcal
- multivalent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201841038835 | 2018-10-12 | ||
| PCT/IN2019/050761 WO2020075201A1 (en) | 2018-10-12 | 2019-10-11 | Multivalent pneumococcal polysaccharide-protein conjugate vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202106179VA true SG11202106179VA (en) | 2021-07-29 |
Family
ID=70164011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202106179VA SG11202106179VA (en) | 2018-10-12 | 2019-10-11 | Multivalent pneumococcal polysaccharide-protein conjugate vaccine |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220143166A1 (en) |
| EP (1) | EP3863667A4 (en) |
| JP (1) | JP2022525492A (en) |
| CN (1) | CN113194987A (en) |
| AU (1) | AU2019358622A1 (en) |
| BR (1) | BR112021012521A2 (en) |
| CA (1) | CA3120926A1 (en) |
| CO (1) | CO2021007863A2 (en) |
| EA (1) | EA202191638A1 (en) |
| IL (1) | IL284349A (en) |
| SG (1) | SG11202106179VA (en) |
| WO (1) | WO2020075201A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20201338A1 (en) | 2017-12-06 | 2020-11-25 | Merck Sharp & Dohme | COMPOSITIONS INCLUDING CONJUGATES OF STREPTOCOCCUS PNEUMONIAE WITH PROTEIN AND METHODS OF USE |
| CN113453708A (en) | 2018-12-19 | 2021-09-28 | 默沙东公司 | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| CN111588842A (en) * | 2020-05-06 | 2020-08-28 | 江苏金迪克生物技术股份有限公司 | Preparation method of multivalent pneumococcal polysaccharide protein conjugate vaccine |
| EP4297776A1 (en) * | 2021-02-26 | 2024-01-03 | Biological E Limited | Activated-quenched polysaccharide and improved methods for quantification of polysaccharide in a vaccine composition |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI445545B (en) * | 2005-04-08 | 2014-07-21 | Wyeth Corp | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| CN103656631B (en) * | 2012-09-24 | 2015-08-19 | 北京科兴中维生物技术有限公司 | multivalent pneumococcal capsular polysaccharide-protein conjugate composition and preparation method thereof |
| HUE053272T2 (en) * | 2015-06-23 | 2021-06-28 | Biological E Ltd | Multivalent pneumococcal conjugate vaccine |
| IL265623B2 (en) * | 2016-09-30 | 2023-04-01 | Biological E Ltd | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates |
| CN108245674A (en) * | 2018-01-18 | 2018-07-06 | 北京智飞绿竹生物制药有限公司 | A kind of prescription of multivalent pneumococcal conjugate combination-vaccine and preparation method thereof |
-
2019
- 2019-10-11 BR BR112021012521-3A patent/BR112021012521A2/en unknown
- 2019-10-11 SG SG11202106179VA patent/SG11202106179VA/en unknown
- 2019-10-11 AU AU2019358622A patent/AU2019358622A1/en active Pending
- 2019-10-11 US US17/312,820 patent/US20220143166A1/en active Pending
- 2019-10-11 JP JP2021534169A patent/JP2022525492A/en active Pending
- 2019-10-11 CA CA3120926A patent/CA3120926A1/en active Pending
- 2019-10-11 EA EA202191638A patent/EA202191638A1/en unknown
- 2019-10-11 EP EP19871190.5A patent/EP3863667A4/en active Pending
- 2019-10-11 WO PCT/IN2019/050761 patent/WO2020075201A1/en active Application Filing
- 2019-10-11 CN CN201980082847.XA patent/CN113194987A/en active Pending
-
2021
- 2021-06-16 CO CONC2021/0007863A patent/CO2021007863A2/en unknown
- 2021-06-24 IL IL284349A patent/IL284349A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022525492A (en) | 2022-05-17 |
| CA3120926A1 (en) | 2020-04-16 |
| EP3863667A4 (en) | 2022-08-17 |
| WO2020075201A1 (en) | 2020-04-16 |
| CO2021007863A2 (en) | 2021-06-21 |
| EP3863667A1 (en) | 2021-08-18 |
| US20220143166A1 (en) | 2022-05-12 |
| AU2019358622A1 (en) | 2021-06-17 |
| IL284349A (en) | 2021-08-31 |
| EA202191638A1 (en) | 2021-12-27 |
| BR112021012521A2 (en) | 2021-09-14 |
| CN113194987A (en) | 2021-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL297575B1 (en) | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates | |
| IL264552A (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| IL276229A (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| ZA202202600B (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| IL264553A (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| ZA201708713B (en) | Multivalent pneumococcal conjugate vaccine | |
| IL281204A (en) | Multivalent pneumococcal vaccines | |
| EP3668541A4 (en) | Pneumococcal conjugate vaccine formulations | |
| ZA201807203B (en) | Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof | |
| EP3585803A4 (en) | Pneumococcal conjugate vaccine formulations | |
| IL284349A (en) | Multivalent pneumococcal polysaccharide-protein conjugate vaccine | |
| ZA201708325B (en) | Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof | |
| IL268168A (en) | Immunogenic compositions for use in pneumococcal vaccines | |
| IL290182A (en) | Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same | |
| ZA201901969B (en) | A composition of multivalent pneumococcal capsular polysaccharide-carrier protein conjugates and use thereof | |
| IL264605A (en) | Multivalent vaccine composition | |
| SG11201911757WA (en) | Novel multivalent polysaccharide - protein conjugate vaccine composition and formulation thereof | |
| EP4090364A4 (en) | Multivalent streptococcus vaccines | |
| ZA202103644B (en) | Multivalent glycoconjugates immunogenic compositions |